Bookmark

Add to MyYahoo RSS

Abbott Laboratories News

News on Abbott Laboratories (Ticker: ABT) continually updated from thousands of sources around the net.

Friday | AmericanBankingNews.com

Absolute Software Receives Outperform Rating from Scotiabank

's stock had its "outperform" rating reiterated by research analysts at Scotiabank in a report released on Friday.

Comment?

Related Topix: Absolute Software, Software

Thu Jul 24, 2014

Bloomberg

Sanofi Drugs Sale Said to Draw Blackstone, KKR Interest

Sanofi 's $8.5 billion portfolio of older, off-patent drugs has drawn interest from private-equity firms KKR & Co., Blackstone Group and TPG Capital, people with knowledge of the matter said.

Comment?

Related Topix: Blackstone Group, Advertising, Facet Biotech, Abbott Labs, Absolute Software, Software

Hispanic Business

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And...

Upon closing, Abbott will receive 105 million shares of the combined company worth approximately , representing an approximately 21% ownership stake.

Comment?

Related Topix: Abbott Labs, Absolute Software, Facet Biotech, Software

Wed Jul 23, 2014

Hispanic Business

Trademark Application for 'Starlims Fusion' Filed by Abbott Laboratories

The serial number for this application is 85323171. As submitted by the applicant, this trademark application relates to the following goods and services: Software programs specifically for use in research and diagnostic laboratories, in particular to enable data interfacing between laboratory instruments and apparatus and laboratory information ... (more)

Comment?

Related Topix: Abbott Labs, Facet Biotech, Absolute Software, Software

Tue Jul 22, 2014

Lake Forester

Dold, Schneider call for government action on corporate inversions

With some of the area's largest corporations considering taking their headquarters to foreign soil, both Rep. Brad Schneider and his challenger, former Rep. Robert Dold , want to see government action.

Comment?

Related Topix: US Politics, US News, US House of Representatives, Representative Brad Schneider, Democrat, Representative Robert Dold, Republican, Walgreens, Retail, Barack Obama, US Senate

GlobeNewswire

Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories,...

Research and Markets has announced the addition of the "Global IVD Market 2014-2018" report to their offering.

Comment?

Related Topix: Facet Biotech, Abbott Labs, Absolute Software, Software, Medicine, Hematology

Mon Jul 21, 2014

TheStreet.com

Will These EPS Estimate Cuts Hurt Abbott Laboratories (ABT) Stock Today?

The analyst firm lowered its EPS estimates for 2015 through 2018 by 7% to 10%. The firm now expects earnings of $2.66 a share in 2015, down from previous estimates of $2.87 a share for the year.

Comment?

Related Topix: Facet Biotech, Abbott Labs, Absolute Software, Software, Financial Markets

Seeking Alpha

AbbVie Gets Its 'Tax Break' In Shire

The pharmaceutical industry has constantly provided us with news of gigantic mergers lately.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Medtronic, Medical Equipment

Fri Jul 18, 2014

Fox News

Will Congress Scuttle the AbbVie-Shire Merger?

AbbVie's $54 billion proposal to acquire Irish drug maker Shire would mark the largest tax inversion ever, as a growing number of U.S. companies pursue lower rates overseas.

Comment?

Related Topix: US News, Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Medtronic, Medical Equipment, Pfizer, Orrin Hatch, US Senate, Republican, US Politics

The Glittering Eye

What Kind of Jobs Do They Want?

Miles White, CEO of Chicago-based Abbott Laboratories, explains corporate inversion , companies' changing of national jurisdictions, frequently seeking tax relief: First, inversion is legal.

Comment?

Related Topix: Facet Biotech, Abbott Labs, Absolute Software, Software, Healthcare Law, Law, Agriculture, Science

Forbes.com

Abbott Raises Full Year Earnings Guidance On Strong Q2 Results

Healthcare giant Abbott Laboratories reported a strong set of second quarter 2014 results on Wednesday, July 16. The company's operational sales increased 3% over the prior year quarter to $5.55 billion, beating analysts' estimates of $5.52 billion compiled by Thomson Reuters.

Comment?

Related Topix: Abbott Labs, Facet Biotech, Absolute Software, Software, Financial Markets

Thu Jul 17, 2014

Benzinga

Markets Sell-Off After Malaysian Airline Crash In Ukraine

U.S. stocks sold off after news reports began to surface that a Malaysian Airlines jet has crashed in Ukraine.

Comment?

Related Topix: Palestinian Territories, World News, Middle East, Apparel, Raymond Ltd, Cable & Satellite, Telecom, Television, Charter Communications, EOG Resources, Oil & Gas, Energy

AmericanBankingNews.com

Abbott Laboratories Given Outperform Rating at Raymond James

's stock had its "outperform" rating reiterated by Raymond James in a research note issued on Thursday.

Comment?

Related Topix: Facet Biotech, Abbott Labs, Absolute Software, Software, Raymond Ltd, Apparel

NutraIngredients-USA

Abbott making 'progress' repairing Fonterra botulism scare damage

Abbott Laboratories' CEO believes the company has "recovered about as well" as it could have in the year since the Fonterra WPC botulism scare that led it to recall infant formula in China, Vietnam, and Saudi Arabia.

Comment?

Related Topix: Botulism, Health

Hispanic Business

Absolute Manage 6.5 also includes Integration with Samsung KNOX Workspace

Organizations now have the ability to secure and manage employee-owned devices beyond the traditional form factors of smartphones and tablets-all from a single console.

Comment?

Related Topix: Absolute Software, Software, Computers, Laptops/Notebooks, Science, Computer Science

Wall Street Journal

Sanofi Looking At Options for Older Drug Lines

French drug maker Sanofi SA has held talks with private-equity firms and rivals including Abbott Laboratories over a potential sale of a set of older drugs valued at 6.3 billion euros , according to a Sanofi document reviewed by The Wall Street Journal.

Comment?

Related Topix: Abbott Labs, Absolute Software, Facet Biotech, Software

Wed Jul 16, 2014

Investor's Business Daily

Abbott, St. Jude Top Views, But Stocks Under Pressure

Medical product giants St. Jude Medical and Abbott Laboratories both beat analysts' Q2 expectations and raised their guidance Wednesday, but their shares had a bumpy ride on the market amid a fresh attack on drug-industry mergers.

Comment?

Related Topix: Medicine, Medical Equipment, Healthcare Industry, St Jude Medical, Financial Markets, Facet Biotech, Abbott Labs, Absolute Software, Software

Hispanic Business

An Application for the Trademark 'ACCELERATOR P540' Has Been Filed by Abbott Laboratories

The international trademark goods and services class code for this trademark application is 009.

Comment?

Related Topix: Facet Biotech, Abbott Labs, Absolute Software, Software, Computers

The Washington Post

Abbott's Asset Sale Provides Ammunition for Perrigo: Real M&A

Free from an underperforming unit, Abbott Laboratories is positioned to go after potential targets from Insulet Corp. to Perrigo Co.

Comment?

Related Topix: Facet Biotech, Abbott Labs, Medicine, Diabetes, Health, Volcano, Healthcare Industry, RBC Financial Group, Banking, Financial Services

Seeking Alpha

Abbott Laboratories' (ABT) CEO, Miles White on Q2 2014 Results - Earnings Call Transcript

Good morning and thank you for standing by. Welcome to Abbott's Second Quarter 2014 Earnings conference call.

Comment?

Related Topix: Abbott Labs

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••